Загрузка...
Forodesine in the treatment of relapsed/refractory peripheral T-cell lymphoma: an evidence-based review
T-cell lymphoma is a rare hematologic malignancy with an incidence rate between 10% and 20% of that of non-Hodgkin lymphomas. Patients with peripheral T-cell lymphoma (PTCL) generally have a poor prognosis when treated with cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP)/CHOP-lik...
Сохранить в:
| Опубликовано в: : | Onco Targets Ther |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5916385/ https://ncbi.nlm.nih.gov/pubmed/29719411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S140756 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|